NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
75 hedge funds and large institutions have $55.1M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 30 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 30
Holders
75
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$1.55M | |
| 2 | +$1.3M | |
| 3 | +$573K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$429K |
| 5 |
N
Natixis
Paris,
France
|
+$288K |
Top Sellers
| 1 | -$2.05M | |
| 2 | -$1.9M | |
| 3 | -$1.15M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$843K |
| 5 |
Two Sigma Investments
New York
|
-$736K |
